TeloCure is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about TeloCure. TeloCure aims to develop a gene therapy for hoyeraal-hreidarsson syndrome, an ultra-rare disease characterized by excessively short telomeres which is considered a severe form of dyskeratosis congenita.
Company size
1-10 employees
Headquarters
Ness-Ziona , HaMerkaz